Why are organic micropollutants not fully biotransformed? A mechanistic modelling approach to anaerobic systems by González Gil, Lorena et al.
SUPPLEMENTARY DATA 
Why are organic micropollutants not fully biotransformed? A mechanistic 
modelling approach to anaerobic systems 
 
Lorena Gonzalez-Gil, Miguel Mauricio-Iglesias*, Marta Carballa, Juan M. Lema 
Department of Chemical Engineering, School of Engineering, Universidade de Santiago 
de Compostela, Rúa Lope Gómez de Marzoa, E-15782 Santiago de Compostela, Spain 
 
* Corresponding author  
 






S1. Batch anaerobic digesters performance ............................................................. 2 
S2. Bootstrap method for model calibration ............................................................ 3 
S3. Initial model screening ....................................................................................... 4 
S4. Model calibration for methanogenesis ............................................................... 6 
S5. Model validation for methanogenesis .............................................................. 10 
S6. Mechanistic model verification in anaerobic digestion systems/overall 
anaerobic process ........................................................ ¡Error! Marcador no definido. 
S7. Comparison of the RMSE in all of the modelling experiments ....................... 18 
 
2 
S1. Batch anaerobic digesters performance 
 
Figure S1. Performance of batch anaerobic digesters (Experiment 4) in terms of COD 
methanized (continuous line) and biogas composition (dashed line) inside the head-space 
of the bottles. 
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S2. Bootstrap method for model calibration 
The bootstrap procedure was done as follows to determine the expected value and the 
confidence interval of the parameters: 
i) Perform a reference parameter estimation using the trust-region-reflective algorithm 
as implemented in Matlab routine lsqnonlin to solve Eq. (S1). 
𝜃∗ = arg min
𝜃






  (S1) 
ii) Estimate the reference residuals (e), which are used to simulate the experimental 
error in the measurements. The residuals are assumed to have equal probability of 
realization (Eq. (S2)). 
𝑒 = 𝐶𝑒𝑥𝑝,𝑘(𝑡𝑖) − 𝐶𝑝𝑟𝑒𝑑,𝑘(𝑡𝑖, 𝜃
∗) (S2) 
iii) Generate synthetic data (C*exp,k) by randomly adding some of the reference residuals 
(random sampling with replacement) to the experimental data (Eq. (S3)). 
𝐶∗𝑒𝑥𝑝,𝑘 = 𝐶𝑒𝑥𝑝,𝑘 + 𝑒𝑗      where ej are elements randomly sampled from e (S3) 
iv) Estimate parameters solving Eq. (S4) for the set of generated synthetic data to find 
the set of parameters 𝜃𝑗  corresponding to iteration j.  
𝜃𝑗 = arg min
𝜃






  (S4) 
v) Iterate through steps iii) and iv). The mean and standard deviation of the distribution 
of 𝜃𝑗  were checked as indications of convergence (number of iterations, nIt = 200). 
vi) It is assumed that for a large nIt, the expected value (Eq. (S5)) can be approximated 
as the mean of 𝜃𝑗  and the confidence interval for a significance  (in this work 0.05) of 







  (S5) 
𝜃𝛼/2 = {𝜃 ∶  𝑃𝑟(𝜃𝑗 ≤ 𝜃𝛼/2) = 𝛼/2}   
𝜃1−𝛼/2 = {𝜃 ∶  𝑃𝑟(𝜃𝑗 ≥ 𝜃1−𝛼/2) = 1 − 𝛼/2} 
(S6) 
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S3. Initial model screening 
Pseudo-first order Michaelis-Menten Inhibition Reversible biotransformation Bioavailability-sequestration 
     
     
Figure S3a. Experimental (dots) and modelled (lines) concentrations of fluoxetine (FLX) and the hormones (E1+E2) using the five 



















































































































































Pseudo-first order Michaelis-Menten Inhibition Reversible biotransformation Bioavailability-sequestration 
     
     
Figure S3b. Experimental (dots) and modelled (lines) concentrations of erythromycin (ERY) and the sulfamethoxazole (SMX) using the five 
























































































































































S4. Model calibration for methanogenesis 













Figure S4a. Experimental (dots) and modelled (lines) concentrations of TCS, NP, OP, 
and TON (Group 1) during methanogenic experiments 1-2. Red and blue colors refer to 






















































































































































































Pseudo-first order Reversible biotransformation Bioavailability-sequestration 
   
   
   
   
Figure S4b. Experimental (dots) and modelled (lines) concentrations of GLX (Group 1), 
CEL (Group 1), EE2 (Group 2), and DZP (Group 2) during methanogenic experiments 1-






















































































































































































Pseudo-first order Reversible biotransformation Bioavailability-sequestration 
   
   
   
   
Figure S4c. Experimental (dots) and modelled (lines) concentrations of BPA (Group 2), 
CBZ (Group 3), ROX (Group 3), and DCF (Group 3) during methanogenic experiments 1-






















































































































































































Pseudo-first order Reversible biotransformation Bioavailability-sequestration 
   
   
   
Figure S4d. Experimental (dots) and modelled (lines) concentrations of NPX (Group 3), 
IBP (Group 3), and TMP (Group 4) during methanogenic experiments 1-2. Red and blue 















































































































































S5. Model validation for methanogenesis 
Pseudo-first order Reversible biotransformation Bioavailability-sequestration 
   
   
   
   
Figure S5a. Model comparison during parameter validation (Experiment 3) of TCS, 
NP, OP, and TON (Group 1). The blue (liquid) and red (solid) areas represent the fate of 






















































































































































































Pseudo-first order Reversible biotransformation Bioavailability-sequestration 
   
   
   
   
Figure S5b. Model comparison during parameter validation (Experiment 3) of GLX 
(Group 1), CEL (Group 1), EE2 (Group 2), and DZP (Group 2). The blue (liquid) and red 






















































































































































































Pseudo-first order Reversible biotransformation Bioavailability-sequestration 
   
   
   
   
Figure S5c. Model comparison during parameter validation (Experiment 3) of BPA 
(Group 2), CBZ (Group 3), ROX (Group 3), and DCF (Group 3). The blue (liquid) and 






















































































































































































Pseudo-first order Reversible biotransformation Bioavailability-sequestration 
   
   
   
Figure S5d. Model comparison during parameter validation (Experiment 3) of NPX 
(Group 3), IBP (Group 3), and TMP (Group 4). The blue (liquid) and red (solid) areas 










































































































































S6. Mechanistic model verification in the overall anaerobic process 
Pseudo-first order Reversible biotransformation Bioavailability-sequestration 
   
   
   
   
Figure S6a. Model comparison to fit the experimental total concentrations (dots) of TCS, 
NP, OP, and TON (Group 1) obtained during batch anaerobic digestion (Experiment 4).  





















































































































































































Pseudo-first order Reversible biotransformation Bioavailability-sequestration 
   
   
   
   
Figure S6b. Model comparison to fit the experimental total concentrations (dots) of 
GLX (Group 1), CEL (Group 1), EE2 (Group 2), and DZP (Group 2) obtained during 
batch anaerobic digestion (Experiment 4).  





















































































































































































Pseudo-first order Reversible biotransformation Bioavailability-sequestration 
   
   
   
   
Figure S6c. Model comparison to fit the experimental total concentrations (dots) of 
BPA (Group 2), CBZ (Group 2), ROX (Group 3), and DCF (Group 3) obtained during 
batch anaerobic digestion (Experiment 4).  





















































































































































































Pseudo-first order Reversible biotransformation Bioavailability-sequestration 
   
   
   
Figure S6d. Model comparison to fit the experimental total concentrations (dots) of 
NPX (Group 3), IBP (Group 3), and TMP (Group 4) obtained during batch anaerobic 
digestion (Experiment 4).  
 
 








































































































































S7. Comparison of the RMSE in all of the modelling experiments 
Table S7. Root mean square errors (RMSE, µg/L) obtained during calibration and validation with methanogenic data and during calibration with 
anaerobic digestion data for the pseudo-first order, the reversible biotransformation and the sequestration models.  























FLX 8.06 4.29 4.30  9.49 4.56 5.16  9.80 3.45 3.36 
TCS 6.62 2.04 2.01  12.4 8.73 9.39  6.43 6.29 6.29 
NP 5.20 3.59 3.63  15.2 12.1 12.1  3.65 1.83 1.88 
OP 10.3 3.81 3.80  8.55 7.36 7.88  3.67 1.82 1.82 
TON 5.74 3.51 3.46  9.09 5.39 5.74  13.4 9.83 7.53 
GLX 6.04 2.62 2.56  6.47 3.43 3.27  5.95 5.38 5.38 







E1+E2* 0.974 0.505 0.471  1.68 0.952 1.04  1.50 1.18 1.19 
EE2* 0.476 0.226 0.192  1.74 1.45 1.46  0.903 0.604 0.604 
DZP 4.48 3.07 3.07  6.80 4.89 5.73  9.94 7.73 7.73 
BPA 6.43 5.36 5.35  7.91 5.27 5.67  6.11 4.55 5.18 







ERY 3.49 3.39 3.47  5.65 5.88 5.11  4.02 4.03 4.03 
ROX 3.13 2.66 2.78  6.72 5.85 5.95  7.43 4.90 4.80 
DCF 5.23 4.95 4.91  10.5 10.6 9.3  13.5 8.38 8.47 
NPX 19.3 15.1 15.2  21.8 15.9 13.9  6.23 5.64 2.69 





SMX 4.24 4.21 4.23  12.4 12.4 11.3  0.70 0.70 0.54 
TMP 8.94 8.52 8.93  12.4 12.4 9.25  10.1 2.82 2.75 
*The RMSE values of E1+E2 and EE2 are lower than the other OMPs because their initial concentration was 20 µg/L instead of 100 µg/L.  
